Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
BörsenkürzelFTRE
Name des UnternehmensFortrea Holdings Inc
IPO-datumJun 16, 2023
CEOMr. Anshul Thakrala
Anzahl der mitarbeiter15500
WertpapierartOrdinary Share
GeschäftsjahresendeJun 16
Addresse8 Moore Drive
StadtDURHAM
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl27709
Telefon18774950816
Websitehttps://www.fortrea.com/
BörsenkürzelFTRE
IPO-datumJun 16, 2023
CEOMr. Anshul Thakrala
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten